Symposium of the Biological Development Center - Accelerating Translation from Discovery to Application

The development of innovative biologicals often stalls at the transition from academic discovery to clinical application.

The Biologicals Development Center, established by NMI and WSIC with EFRE support, aims to address this challenge by providing comprehensive infrastructure and expertise for the design, production, functionalization, and evaluation of biologicals across therapeutic, diagnostic, and biofunctional domains.

This workshop offers insights into scientific, technological, and manufacturing challenges that shape the future of biologicals. The program includes contributions from the project’s steering committee and invited industry partners.

In addition, the current status of the Center will be presented demonstrating how shared analytical capabilities and structured developability approaches can accelerate early biologicals development.

Together, we explore how coordinated resources and cross‑sector collaboration can strengthen regional innovation and enable biologicals to reach real‑world application faster.

Presentations by:

Dr. Anne Zeck (NMI): Developability of Nanobody Tracers

Dr. Jan Chemnitz (Provirex): The future if HIV therapy; PROVIREX Technology: error-free genome editing

Prof. Dr. Margret Schottelius (Universität Lausanne): Imaging the TME - opportunities and challenges

Thilo Grob (Rentschler Biopharma): Trends in Biological Manufacturing

Dr. Jörg Regula (Boehringer Ingelheim): tbd

Dr. Michael Molhoj (Immatics): tbd

Prof. Dr. Johannes Schwenck (Universitätsklinikum Tübingen): Clinical Molecular Imaging - State of the art and future trends